Thus, in recent years, the study of how DPP4 inhibition can affect other pathologies associated with cardiovascular or renal systems, as well as bone metabolism, for example, has increased; many of them are related to T2DM [8,9,10]. Here, DPP4 is linked to type 2 diabetes mellitus.